Advertisement
UK markets open in 55 minutes
  • NIKKEI 225

    37,676.85
    -783.23 (-2.04%)
     
  • HANG SENG

    17,237.95
    +36.68 (+0.21%)
     
  • CRUDE OIL

    82.92
    +0.11 (+0.13%)
     
  • GOLD FUTURES

    2,332.10
    -6.30 (-0.27%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    51,464.84
    -1,995.06 (-3.73%)
     
  • CMC Crypto 200

    1,391.60
    +9.02 (+0.65%)
     
  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Why Gilead Sciences Stock Was a 5% Winner Today

Gilead Sciences (NASDAQ: GILD) stock was off to a good start this week, rising by more than 5% on Monday against the modest (0.4%) gain of the S&P 500 index. The prominent pharmaceutical company had some good news to impart about an important cancer drug. Gilead announced that morning that its breast cancer treatment Trodelvy recorded "statistically significant and clinically meaningful" results in a phase 3 clinical trial.